Next Science Limited (NXSCF)

OTCMKTS · Delayed Price · Currency is USD
0.0420
0.00 (0.00%)
Jul 9, 2025, 4:00 PM EDT
-75.29%
Market Cap 25.75M
Revenue (ttm) 22.82M
Net Income (ttm) -10.59M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 12,345
Open 0.0470
Previous Close 0.0420
Day's Range 0.0420 - 0.0470
52-Week Range 0.0052 - 0.1967
Beta 1.31
RSI 50.13
Earnings Date Jul 25, 2025

About Next Science

Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, i... [Read more]

Sector Healthcare
Founded 2012
Country Australia
Stock Exchange OTCMKTS
Ticker Symbol NXSCF
Full Company Profile

Financial Performance

In 2024, Next Science's revenue was $22.82 million, an increase of 2.87% compared to the previous year's $22.18 million. Losses were -$10.59 million, -34.94% less than in 2023.

Financial Statements

News

There is no news available yet.